A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA

Genes and Development

Volumn 14, Issue 2, 2000, Pages 187-197

  Bitzer, Markus ^a   Von Gersdorff, Gero ^a   Liang, Dan ^a   Dominguez Rosales, Alfredo ^a   Beg, Amer A ^b   Rojkind, Marcos ^a   Böttinger, Erwin P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Cytokines; NF B; Signal transduction; SMADs; TGF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENTARY RNA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE RELEASE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; COS CELLS; DNA-BINDING PROTEINS; LIGASES; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 0034650266     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Arsura, M., M. Wu, and G.E. Sonenshein. 1996. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha. Immunity 5: 31-40.
2. Arsura, M., M.J. FitzGerald, N. Fausto, and G.E. Sonenshein. 1997. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 8: 1049-1059.
3. Baeuerle, P.A. and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12: 141-179.
4. Baldwin, A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
5. Ballermann, B.J., A. Dardik, E. Eng, and A. Liu. 1998. Shear stress and the endothelium. Kidney Int. Suppl. 67: S100-S108.
6. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170.
7. Böttinger, E.P., J.L. Jakubczak, I.S. Roberts, M. Mumy, P. Hemmati, K. Bagnall, G. Merlino, and L.M. Wakefield. 1997. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16: 2621-2633.
8. Brown, A.M., M.W. Linhoff, B. Stein, K.L. Wright, A.S. Baldwin, Jr., P.V. Basta, and J.P. Ting. 1994. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits. Mol. Cell Biol. 14: 2926-2935.
9. Chen, X., M.J. Rubock, and M. Whitman. 1997. A transcriptional partner for MAD proteins in TGF-beta signalling. Nature 383: 691-696.
10. Chung, K.Y., A. Agarwal, J. Uitto, and A. Mauviel. 1996. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271: 3272-3278.
11. Derynck, R. and X.H. Feng. 1997. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333: F105-F150.
12. Derynck, R., Y. Zhang, and X.H. Feng. 1998. Smads: Transcriptional activators of TGF-beta responses. Cell 95: 737-740.
13. Garcia-Trevijano, E.R., M.J. Iraburu, L. Fontana, J.A. Dominguez-Rosales, A. Auster, A. Covarrubias-Pinedo, and M. Rojkind. 1999. Transforming growth factor beta 1 induces the expression of alphal(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology 29: 960-970.
14. Geiser, A.C., J.K. Burmester, R. Webbink, A.B. Roberts, and M.B. Sporn. 1992. Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem. 267: 2588-2593.
15. Geiser, A.G., J.J. Letterio, A.B. Kulkarni, S. Karlsson, A.B. Roberts, and M.B. Sporn. 1993. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc. Natl. Acad. Sci. 90: 9944-9948.
16. Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
17. Grilli, M., J.J. Chiu, and M.J. Lenardo. 1993. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62.
18. Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A.J. Gimbrone, J.L. Wrana, and D. Falb. 1997. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89: 1165-1173.
19. Heldin, C.H., K. Miyazono, and P. ten Dijke. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
20. Hoodless, P.A. and J.L. Wrana. 1998. Mechanism and function of signaling by the TGF beta superfamily. Curr. Top. Microbiol. Immunol. 228: 235-272.
21. Inagaki, Y., S. Truter, S. Tanaka, M. Di Liberto, and F. Ramirez. 1995. Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(1) collagen gene transcription. J. Biol. Chem. 270: 3353-3358.
22. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell 76: 253-262.
23. Kretzschmar, M. and J. Massagué. 1998. SMADs: Mediators and regulators of TGF-beta signaling. Curr. Opin. Genet. Dev. 8: 103-111.
24. Lefer, A.M., X.L. Ma, A.S. Weyrich, and R. Scalia. 1993. Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. 90: 1018-1022.
25. Letterio, J.J. and A.B. Roberts. 1997. TGF-beta: a critical modulator of immune cell function. Clin. Immunol. Immunopathol. 84: 244-250.
26. _. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol 16: 137-161.
27. Li, J.M., X. Shen, P.P. Hu, and X.F. Wang. 1998. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity. Mol. Cell. Biol. 18: 110-121.
28. Liu, X., Y. Sun, S.N. Constantinescu, E. Karam, R.A. Weinberg, and H.F. Lodish. 1997. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. 94: 10669-10674.
29. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
30. Massagué, J. 1998. TGF-beta signal transduction. Annu. Rev. Biochem. 67: 753-791.
31. Muller, J.M., H.W. Ziegler-Heitbrock, and P.A. Baeuerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256.
32. Mundel, P., J. Reiser, A.Z. Borja, H. Pavenstadt, G.R. Davidson, W. Kriz, and R. Zeller. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236: 248-258.
33. Nakao, A., M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, C.H. Heldin, and P. ten Dijke. 1997a. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635.
34. Nakao, A., E. Roijer, T. Imamura, S. Souchelnytskyi, G. Stenman, C.H. Heldin, and P. ten Dijke. 1997b. Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway. J. Biol. Chem. 272: 2896-2900.
35. Oberhammer, F.A., M. Pavelka, S. Sharma, R. Tiefenbacher, W. Bursch, and R. Schuhe-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl. Acad. Sci. 89: 5408-5412.
36. Ouaaz, F., M. Li, and A.A. Beg. 1999. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J. Exp. Med. 189: 999-1004.
37. Snoeck, H.W., S. Weekx, A. Moulijn, F. Lardon, M. Lenjou, G. Nys, P.C. Van Ranst, D.R. Van Bockstaele, and Z.N. Berneman. 1996. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma. J. Exp. Med. 183: 705-710.
38. Topper, J.N., J. Cai, Y. Qiu, K.R. Anderson, Y.Y. Xu, J.D. Deeds, R. Feeley, C.J. Gimeno, E.A. Woolf, O. Tayber et al. 1997. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. 94: 9314-9319.
39. Ulloa, L., J. Doody, and J. Massague. 1999. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397: 710-713.
40. Vodovotz, Y., A.C. Geiser, L. Chesler, J.J. Letterio, A.J. Campbell, M.S. Lucia, M.B. Sporn, and A.B. Roberts. 1996. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. J. Exp. Med. 183: 2337-2342.
41. Wahl, S.M. 1994. Transforming growth factor beta: The good, the bad, and the ugly. J. Exp. Med. 180: 1587-1590.
42. Wrana, J.L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.F. Wang, and J. Massagué. 1992. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.
43. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-beta receptor. Nature 370: 341-347.
44. Zawel, L., J.L. Dai, P. Buckhaults, S. Zhou, K.W. Kinzler, B. Vogelstein, and S.E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1: 611-617.